SCHEMBL22908181

SCHEMBL22908181

c1ccc2c(-c3c4ccccc4c(-c4cccc5c4oc4cc6oc7ccccc7c6cc45)c4ccccc34)cccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.47
AHR P35869 2/20 0.41
MAOA P21397 1/20 0.41
PRKDC P78527 5/20 0.41
PIK3CD O00329 1/20 0.40
PIK3CB P42338 1/20 0.40
MAPT P10636 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
GAA P10253 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ATM Q13315 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DUSP3 P51452 1/20 0.38
PSD A5PKW4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18268522 0.96 ALOX5 (0.48) ALOX5AHRPRKDCPIK3CDPIK3CB
SCHEMBL125837 0.91 ALOX5 (0.50) ALOX5AHRPRKDCPIK3CDPIK3CB
SCHEMBL20334709 0.90 ALOX5 (0.52) ALOX5AHRMAOAPRKDCPIK3CD
SCHEMBL20334253 0.88 ALOX5 (0.52) ALOX5AHRMAOAPRKDCPIK3CD
SCHEMBL22707783 0.88 ALOX5 (0.52) ALOX5AHRMAOAPRKDCPIK3CD
SCHEMBL21881091 0.88 ALOX5 (0.51) ALOX5AHRMAOAPRKDCPIK3CD
SCHEMBL27329513 0.88 ALOX5 (0.44) ALOX5AHRMAOAPRKDCPIK3CD
SCHEMBL24662714 0.87 AHR (0.42) AHRMAOAMAPTKDM4EALDH1A1
SCHEMBL24662817 0.87 ALOX5 (0.47) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL17932052 0.87 ALOX5 (0.40) ALOX5MAOAMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4242196-A1 METHOD FOR PREPARING DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND AND COMPOSITION Lg Chem, Ltd. (KR) 2023-09-13 EP disclosed
WO-2022169218-A1 METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION 주식회사 엘지화학 2022-08-11 WO disclosed
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, OR51E2, LOXL1 ALOX5 1073/4885AHR 3266/4885MAOA 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.